NX-5948 has received fast track designation for adults with relapsed or refractory Waldenström macroglobulinemia who received ...

Zanubrutinib is under clinical development by BeiGene and currently in Phase II for Unspecified B-Cell Lymphomas.

Chronic lymphocytic leukemia (CLL) is a type of cancer that affects white blood cells (WBCs). Since these blood cells are part of the immune system, CLL affects the body’s ability to fight germs.

Vactosertib is under clinical development by MedPacto and currently in Phase I for Acute Lymphoblastic Lymphoma.

A trio of experts discuss the treatment of chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL) with Bruton ...

The rocker debuts the music video for "Transition" as he searches for a donor. "My donor will be my one in a million, my ...

CURE® highlights some top stories from the ASH Annual Meeting, focusing on B-cell acute lymphoblastic leukemia, multiple ...

The randomized phase III AALL1731 trial presented at the American Society of Hematology annual meeting showed that adding the bispecific T-cell engager blinatumomab (Blincyto) to chemotherapy ...